FDA Approved: ABIRATERONE ACETATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for a generic abiraterone acetate, manufactured by Rising Pharma Holdings, expanding access for treatment of metastatic ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

ORIG AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)